Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Concurrent Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer: A Prospective Feasibility Trial

NCT03958721 is registered in ClinicalTrials.gov with A Bapsi Chakravarthy, MD as lead sponsor.

NCT NCT03958721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03958721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Concurrent Capecitabine and Radiotherapy in the Adjuvant Treatment of Resistant Breast Cancer: A Prospective Feasibility Trial
Lead sponsor
A Bapsi Chakravarthy, MD
Phase
Phase 1
Overall status
Completed
Start date
July 18, 2019
Completion date
October 26, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-metastatic invasive breast cancer, resistant breast cancer